Core Scientific Inc (NASDAQ:CORZ) does about 12.86M shares in volume on a normal day but saw 7297478 shares change hands in the recent trading day. The company now has a market cap of 2.50B USD. Its current market price is $9.70, marking a decrease of -4.34% compared to the previous close of $10.14. The 52 week high reached by this stock is $12.25 whilst the lowest price level in 52 weeks is $2.61. The script in recent trading has seen the stock touch a high of $17 and a low of $3.
Core Scientific Inc (CORZ) has a 20-day trading average at $10.03 and the current price is -20.82% off the 52-week high compared with 271.65% distance from its 52-week low. The 50-day simple moving average of the closing price is $9.30. If we look at the stock’s price movements over the week, volatility stands at 14.10%, which decreases to 10.13% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 50.76 to suggest the stock is neutral.
The consensus objective for the share price is $15.43, suggesting that the stock has a potential upside of 37.14% over the period. The median price target is 22.4% away from the current levels at $12.5.
6 analysts have rated it as a buy and 0 have advised that investors hold their positions. The consensus recommendation rating is Buy and Wall Street’s advice is for investors to Strong Buy the stock.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on July 17, 2024 when B. Riley Securities upgraded the stock to “Buy” and issued a price target of $13. Bernstein initiated its price target at $17.
Core Scientific Inc (CORZ) stock is up 9.11% over the week and -0.10% over the past month. Its price is 181.98% year-to-date.
The company’s next earnings report forecasts estimating quarterly EPS at -0.08 and 0.13 for whole year. Expected sales for next quarter are $111.09M, which analysts say will come at $534.73M for the current fiscal year and next year at $704.18M. In addition, estimates put the company’s current quarterly revenue at an average of $101.76M.
Its 12-month price target is $12.5. To reach the target analysts have set, the stock logically needs to grow 37.14 percent from here. Of course, the average price target is just what the average analysts believe a stock will be worth in the next 52 weeks, and is only one metric. There are analysts with lower targets than the average, including one bearish Wall Street research firm advocating investors to wait for the price to pull back to $3, given the recent momentum. And then, on the bullish side of things, one analyst is expecting the stock to peak at $17.
Outstanding shares total 386.88M with insiders holding 11.31% of the shares and institutional holders owning 25.59% of the company’s common stock. The company has a return on equity of -7418.13%. The forward price to earnings ratio is 18.79. Price to sales ratio is 4.35.
